# Gyre Therapeutics, Inc.: Form 8-K, filed Jun 2, 2026

- Company: [Gyre Therapeutics, Inc.](/companies/gyre.md) (CIK 1124105)
- Form: 8-K
- Filed: 2026-06-02
- Accepted by EDGAR: Jun 2, 2026, 06:09 ET
- Period: 2026-06-01
- Accession: 0001140361-26-023625
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1124105/000114036126023625/ef20075381_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1124105/000114036126023625/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1124105/000114036126023625/ef20075381_8k.htm

Filed Jun 2, 2026.
Source: SEC EDGAR, the filing index for accession 0001140361-26-023625. Last ingested by Listed: Nov 5, 2026, 18:44 ET. No prices; not investment advice.